| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Association between skeletal muscle loss and the response to nivolumab immunotherapy in advanced gastric cancer patients
|
Kano, Mikihiro
|
|
|
26 |
3 |
p. 523-531
|
artikel
|
| 2 |
Bevacizumab-associated events in Japanese women with cervical cancer: a multi-institutional survey of Obstetrical Gynecological Society of Kinki district, Japan
|
Mabuchi, Seiji
|
|
|
26 |
3 |
p. 598-605
|
artikel
|
| 3 |
Characteristics and outcomes of coronavirus disease 2019 (COVID-19) patients with cancer: a single-center retrospective observational study in Tokyo, Japan
|
Nakamura, Shohei
|
|
|
26 |
3 |
p. 485-493
|
artikel
|
| 4 |
Cryoablation, high-intensity focused ultrasound, irreversible electroporation, and vascular-targeted photodynamic therapy for prostate cancer: a systemic review and meta-analysis
|
Guo, Run-Qi
|
|
|
26 |
3 |
p. 461-484
|
artikel
|
| 5 |
Diagnostic accuracies of intraoperative frozen section and permanent section examinations for histological grades during open biopsy of bone tumors
|
Miwa, Shinji
|
|
|
26 |
3 |
p. 613-619
|
artikel
|
| 6 |
Effectiveness and safety of nivolumab in patients with head and neck cancer in Japanese real-world clinical practice: a multicenter retrospective clinical study
|
Hanai, Nobuhiro
|
|
|
26 |
3 |
p. 494-506
|
artikel
|
| 7 |
Efficacy and safety of darolutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a sub-group analysis of the phase III ARAMIS trial
|
Uemura, Hiroji
|
|
|
26 |
3 |
p. 578-590
|
artikel
|
| 8 |
Is it a case series? Comment on “Efficacy of modified FOLFOX6 chemotherapy for patients with unresectable pseudomyxoma peritonei”
|
Luo, Min
|
|
|
26 |
3 |
p. 620
|
artikel
|
| 9 |
Limited resection vs. pancreaticoduodenectomy for primary duodenal adenocarcinoma: a systematic review and meta-analysis
|
Burasakarn, Pipit
|
|
|
26 |
3 |
p. 450-460
|
artikel
|
| 10 |
Oncologic outcomes and safety of percutaneous cryoablation for biopsy-proven renal cell carcinoma up to 4 cm in diameter: a prospective observational study
|
Gobara, Hideo
|
|
|
26 |
3 |
p. 562-568
|
artikel
|
| 11 |
Phase II study of the combination of S-1 with bevacizumab for patients with previously treated advanced non-squamous non-small-cell lung cancer
|
Hasegawa, Tsukasa
|
|
|
26 |
3 |
p. 507-514
|
artikel
|
| 12 |
Predictive role of γ-glutamyltransferase in patients receiving nivolumab therapy for metastatic renal cell carcinoma
|
Ishiyama, Yudai
|
|
|
26 |
3 |
p. 552-561
|
artikel
|
| 13 |
Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naïve squamous cell carcinoma: North Japan lung cancer study group 1302
|
Kawashima, Yosuke
|
|
|
26 |
3 |
p. 515-522
|
artikel
|
| 14 |
Reply to comments on “Efficacy of modified FOLFOX6 chemotherapy for patients with unresectable pseudomyxoma peritonei”
|
Hiraide, Sakura
|
|
|
26 |
3 |
p. 621
|
artikel
|
| 15 |
Risk factors for gemcitabine plus nab-paclitaxel-induced interstitial lung disease in pancreatic cancer patients
|
Takeda, Tsuyoshi
|
|
|
26 |
3 |
p. 543-551
|
artikel
|
| 16 |
Risk factors for lymph node metastasis in cutaneous squamous cell carcinoma: a long-term retrospective study of Japanese patients
|
Saito, Yuki
|
|
|
26 |
3 |
p. 606-612
|
artikel
|
| 17 |
The efficacy of a third-generation oncolytic herpes simplex viral therapy for an HPV-related uterine cervical cancer model
|
Kagabu, Masahiro
|
|
|
26 |
3 |
p. 591-597
|
artikel
|
| 18 |
The initial assessment of expert panel performance in core hospitals for cancer genomic medicine in Japan
|
Sunami, Kuniko
|
|
|
26 |
3 |
p. 443-449
|
artikel
|
| 19 |
The metabolic syndrome is associated with the risk of urothelial carcinoma from a health examination database
|
Lee, Hsiang-Ying
|
|
|
26 |
3 |
p. 569-577
|
artikel
|
| 20 |
TRIM37 overexpression is associated with chemoresistance in hepatocellular carcinoma via activating the AKT signaling pathway
|
Tan, Guosheng
|
|
|
26 |
3 |
p. 532-542
|
artikel
|
Tijdschrift beschrijving